Trial Profile
Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 Mg/Day or 20 Mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US, EFC4964) - A Randomized, Double-Blind, 3-Arm, Placebo-Controlled, Parallel-Group, Fixed-Dose, 52-Week, Multi-Center Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2019
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms STRATUS-US
- Sponsors Sanofi
- 14 Jul 2009 New trial record